» Articles » PMID: 28143449

Cancers of Unknown Primary Diagnosed During Hospitalization: a Population-based Study

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2017 Feb 2
PMID 28143449
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancers of Unknown Primary (CUP) are the 3-4 most common causes of cancer death and recent clinical guidelines recommend that patients should be directed to a team dedicated to their care. Our aim was to inform the care of patients diagnosed with CUP during hospital admission.

Methods: Descriptive study using hospital admissions (Scottish Morbidity Record 01) linked to cancer registrations (ICD-10 C77-80) and death records from 1998 to 2011 in West of Scotland, UK (population 2.4 m). Cox proportional hazards models were used to assess effects of baseline variables on survival.

Results: Seven thousand five hundred ninety nine patients were diagnosed with CUP over the study period, 54.4% female, 67.4% aged ≥ 70 years, 36.7% from the most deprived socio-economic quintile. 71% of all diagnoses were made during a hospital admission, among which 88.6% were emergency presentations and the majority (56.3%) were admitted to general medicine. Median length of stay was 15 days and median survival after admission 33 days. Non-specific morphology, emergency admission, age over 60 years, male sex and admission to geriatric medicine were all associated with poorer survival in adjusted analysis.

Conclusions: Patients with a diagnosis of CUP are usually diagnosed during unplanned hospital admissions and have very poor survival. To ensure that patients with CUP are quickly identified and directed to optimal care, increased surveillance and rapid referral pathways will be required.

Citing Articles

Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia.

Boys E, Gao B, Grimison P, Sutherland S, Mackenzie K, Reddel R Cancer Med. 2024; 13(6):e7052.

PMID: 38523552 PMC: 10961596. DOI: 10.1002/cam4.7052.


Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary.

Harvey S, Stares M, Scott J, Thottiyil T, Conway A, Haigh R Cancer Med. 2024; 13(3):e6988.

PMID: 38404120 PMC: 10895198. DOI: 10.1002/cam4.6988.


Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis.

Al Assaad M, Shin N, Sigouros M, Manohar J, Antysheva Z, Kotlov N Front Oncol. 2024; 13:1274163.

PMID: 38318324 PMC: 10838960. DOI: 10.3389/fonc.2023.1274163.


Patient characteristics associated with definitive diagnosis of metastatic pancreatic cancer in those initially diagnosed with cancer of unknown primary.

Lee White L, Smith-Gagen J, Elliott L, Lu M Mol Clin Oncol. 2023; 19(6):101.

PMID: 38022848 PMC: 10666077. DOI: 10.3892/mco.2023.2697.


Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance-A Retrospective, Long-Term Single-Center Experience.

Schmidt M, Hinterleitner C, Singer S, Lauer U, Zender L, Hinterleitner M Cancers (Basel). 2023; 15(17).

PMID: 37686593 PMC: 10486951. DOI: 10.3390/cancers15174316.


References
1.
Brewster D, Lang J, Bhatti L, Thomson C, Oien K . Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010. Cancer Epidemiol. 2014; 38(3):227-34. DOI: 10.1016/j.canep.2014.03.010. View

2.
Hemminki K, Ji J, Sundquist J, Shu X . Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol. 2010; 29(4):435-40. DOI: 10.1200/JCO.2010.31.5614. View

3.
Pavlidis N, Pentheroudakis G . Cancer of unknown primary site. Lancet. 2012; 379(9824):1428-35. DOI: 10.1016/S0140-6736(11)61178-1. View

4.
Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D . Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care. Aust N Z J Public Health. 2008; 32(4):383-9. DOI: 10.1111/j.1753-6405.2008.00260.x. View

5.
Pavlidis N, Pentheroudakis G . Cancer of unknown primary site: 20 questions to be answered. Ann Oncol. 2010; 21 Suppl 7:vii303-7. DOI: 10.1093/annonc/mdq278. View